Plasma Concentration Clinical Trial
Official title:
A Randomised, Open-label, 4-way Crossover Study in Healthy Subjects to Explore the Performance of IntelliCap® by Comparing Pharmacokinetic Profiles of a Probe Drug.
This is an open-label, randomised, 4-way crossover study in twelve healthy male volunteers.
The study will characterise the performance of IntelliCap® by evaluating the plasma
concentration and pharmacokinetic profile of a probe drug (IMP; metoprolol) released from
IntelliCap® with three different release profiles and the plasma concentration and
pharmacokinetic profile of the same probe drug after a single dose of an oral solution.
n/a
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06120543 -
CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in Adult Patients With Depression
|
||
| Active, not recruiting |
NCT04735913 -
Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults
|
Early Phase 1 | |
| Recruiting |
NCT03092128 -
A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment
|